RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Comparing Regulation of IVD Medical Devices in Europe and Canada

Comparing Regulation of IVD Medical Devices in Europe and Canada

Posted 01 May 2011 | By Ivor Barrett 

In vitro diagnostic (IVD) medical devices are reagents and related instruments used to test specimens derived from the human body to obtain information regarding physiological and pathological conditions, congenital abnormalities, compatibility of potential recipients of blood transfusions and tissue transplants and effectiveness of therapy. As the results of these tests are used to inform crucial clinical decisions, regulation of IVD devices is seen in many regions of the world as an important requirement to protect patient safety.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.